Cue Biopharma (CUE) Price to FCF (2018 - 2025)

Cue Biopharma has disclosed Price to FCF across 8 years of filings, most recently posting 821.64 for Q4 2025.

• In Q4 2025, Price to FCF fell 267.03% year-over-year to 821.64; the TTM figure through Dec 2025 stood at 40.44 (up 27.2% YoY), while the FY2025 annual figure was 40.44, up 27.2% from the prior year.
• Price to FCF came in at 821.64 for Q4 2025 at Cue Biopharma, down from 241.11 in the prior quarter.
• In the past five years, Price to FCF ranged from a high of 180.95 in Q2 2024 to a low of 2064.51 in Q3 2021.
• Average Price to FCF over 5 years is 528.41, with a median of 370.24 recorded in 2023.
• Year-over-year, Price to FCF slumped 1102.07% in 2021 and jumped 83.5% in 2022.
• Over 5 years, Price to FCF stood at 1026.41 in 2021, then jumped by 71.76% to 289.87 in 2022, then fell by 17.73% to 341.25 in 2023, then surged by 34.4% to 223.86 in 2024, then slumped by 267.03% to 821.64 in 2025.
• Per Business Quant data, the three most recent Price to FCF figures were 821.64 in Q4 2025, 241.11 in Q3 2025, and 454.42 in Q2 2025.